N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry
© 2021. The Author(s)..
N-glycosylation plays an important role in the structure and function of membrane and secreted proteins. The spike protein on the surface of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, is heavily glycosylated and the major target for developing vaccines, therapeutic drugs and diagnostic tests. The first major SARS-CoV-2 variant carries a D614G substitution in the spike (S-D614G) that has been associated with altered conformation, enhanced ACE2 binding, and increased infectivity and transmission. In this report, we used mass spectrometry techniques to characterize and compare the N-glycosylation of the wild type (S-614D) or variant (S-614G) SARS-CoV-2 spike glycoproteins prepared under identical conditions. The data showed that half of the N-glycosylation sequons changed their distribution of glycans in the S-614G variant. The S-614G variant showed a decrease in the relative abundance of complex-type glycans (up to 45%) and an increase in oligomannose glycans (up to 33%) on all altered sequons. These changes led to a reduction in the overall complexity of the total N-glycosylation profile. All the glycosylation sites with altered patterns were in the spike head while the glycosylation of three sites in the stalk remained unchanged between S-614G and S-614D proteins.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Scientific reports - 11(2021), 1 vom: 07. Dez., Seite 23561 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Dongxia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Angiotensin-Converting Enzyme 2 |
---|
Anmerkungen: |
Date Completed 15.12.2021 Date Revised 13.09.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41598-021-02904-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM33413238X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM33413238X | ||
003 | DE-627 | ||
005 | 20231226203939.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41598-021-02904-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1113.xml |
035 | |a (DE-627)NLM33413238X | ||
035 | |a (NLM)34876606 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Dongxia |e verfasserin |4 aut | |
245 | 1 | 0 | |a N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.12.2021 | ||
500 | |a Date Revised 13.09.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021. The Author(s). | ||
520 | |a N-glycosylation plays an important role in the structure and function of membrane and secreted proteins. The spike protein on the surface of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, is heavily glycosylated and the major target for developing vaccines, therapeutic drugs and diagnostic tests. The first major SARS-CoV-2 variant carries a D614G substitution in the spike (S-D614G) that has been associated with altered conformation, enhanced ACE2 binding, and increased infectivity and transmission. In this report, we used mass spectrometry techniques to characterize and compare the N-glycosylation of the wild type (S-614D) or variant (S-614G) SARS-CoV-2 spike glycoproteins prepared under identical conditions. The data showed that half of the N-glycosylation sequons changed their distribution of glycans in the S-614G variant. The S-614G variant showed a decrease in the relative abundance of complex-type glycans (up to 45%) and an increase in oligomannose glycans (up to 33%) on all altered sequons. These changes led to a reduction in the overall complexity of the total N-glycosylation profile. All the glycosylation sites with altered patterns were in the spike head while the glycosylation of three sites in the stalk remained unchanged between S-614G and S-614D proteins | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Glycopeptides |2 NLM | |
650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
700 | 1 | |a Zhou, Bin |e verfasserin |4 aut | |
700 | 1 | |a Keppel, Theodore R |e verfasserin |4 aut | |
700 | 1 | |a Solano, Maria |e verfasserin |4 aut | |
700 | 1 | |a Baudys, Jakub |e verfasserin |4 aut | |
700 | 1 | |a Goldstein, Jason |e verfasserin |4 aut | |
700 | 1 | |a Finn, M G |e verfasserin |4 aut | |
700 | 1 | |a Fan, Xiaoyu |e verfasserin |4 aut | |
700 | 1 | |a Chapman, Asheley P |e verfasserin |4 aut | |
700 | 1 | |a Bundy, Jonathan L |e verfasserin |4 aut | |
700 | 1 | |a Woolfitt, Adrian R |e verfasserin |4 aut | |
700 | 1 | |a Osman, Sarah H |e verfasserin |4 aut | |
700 | 1 | |a Pirkle, James L |e verfasserin |4 aut | |
700 | 1 | |a Wentworth, David E |e verfasserin |4 aut | |
700 | 1 | |a Barr, John R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 11(2021), 1 vom: 07. Dez., Seite 23561 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2021 |g number:1 |g day:07 |g month:12 |g pages:23561 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41598-021-02904-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2021 |e 1 |b 07 |c 12 |h 23561 |